98%
921
2 minutes
20
This study explores the regulatory effects of raspberry extract (RBE) as a natural inhibitor on the ethyl carbamate (EC) formation during the fermentation of Chinese rice wine (CRW) and assesses its impact on the wine's quality. We incorporated varying concentrations of RBE (250, 500, and 1000 mg·L) into both the fermentation mash of CRW and a simulated fermentation system. Systematic monitoring included the EC content, levels of precursors (urea, arginine, citrulline), activities of key enzymes (ADIase, OTCase, arginase, urease), and the impact of RBE on relevant genes' transcriptional levels. The study was further complemented by transcriptome sequencing. The molecular regulation mechanism of RBE on Saccharomyces cerevisiae's metabolic processes was analyzed. We found that 500 mg·L RBE notably reduced EC production and inhibited urea accumulation while also affecting citrulline metabolism by regulating the activities of the ADIase and OTCase enzymes. Transcriptome analysis revealed the extensive impact of RBE on gene expression in S. cerevisiae. Additionally, when the concentration of RBE was 500 mg·L or higher, it notably influenced the volatile aroma and free amino acid content of the resulting wine, thereby enriching its flavor. This study systematically elucidates the inhibitory effect on EC production and the multifaceted impacts of RBE in CRW fermentation, providing a novel natural inhibitor for the prevention and control of EC in fermented products and laying the groundwork for understanding the mechanism by which RBE inhibits EC formation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/1750-3841.70461 | DOI Listing |
Med Phys
September 2025
Department of Accelerator and Medical Physics, National Institutes for Quantum Science and Technology (QST), Chiba, Japan.
Background: Multi-ion radiotherapy using carbon, oxygen, and neon ions aims to improve local control by increasing dose-averaged linear energy transfer (LET) in the target. However, there has been limited understanding of how to utilize variables for multi-ion treatment planning such as the selection and arrangement of ion species.
Purpose: An in silico study was conducted to explore the feasibility of increasing a minimum LET, and the optimal selection and arrangement of ion species in multi-ion therapy for increasing LET in tumors of varying sizes mimicking bone and soft tissue sarcomas (BSTS).
Oral Dis
September 2025
Clinical Department, Radiation Oncology Unit, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
Aim: To evaluate the outcomes of combining carbon ion radiotherapy boost (CIRTb) with photons (Ph) or protons (PT) for locally advanced salivary gland and sinonasal cancers (SGCs and SNCs).
Materials And Methods: Sixty-nine patients with SGCs and SNCs received CIRTb to high-risk CTV and Ph or PT to low-risk CTV (LR-CTV) from October 2014 to September 2022. Two-year local relapse-free survival (LRFS) was analyzed with Kaplan-Meier.
J Neurooncol
September 2025
Department of Radiation Oncology, Massachusetts General Hospital, Boston, USA.
Purpose: Cranial irradiation is associated with health-related quality of life (HRQoL) deficits in childhood cancer survivors. We investigated the relationship between radiation dose to brain substructures and HRQoL in children with brain tumors treated with proton beam therapy (PBT).
Methods: Data were obtained from children in the Pediatric Proton/Photon Consortium Registry who received PBT for primary brain tumors between 2015 and 2021.
Exp Dermatol
September 2025
Department of Surgery, Chang Bing Show Chwan Memorial Hospital, Lukang, Taiwan.
Radiation dermatitis is a common side effect of radiotherapy, affecting up to 95% of cancer patients receiving radiation therapy and often leading to skin damage, inflammation, and ulceration. The pathogenesis of radiation dermatitis involves complex mechanisms, such as the production of reactive oxygen species (ROS) and sustained inflammatory responses. Current treatments, including topical steroids, moisturisers, and non-steroidal anti-inflammatory drugs (NSAIDs), often provide limited efficacy, primarily addressing symptoms rather than the underlying pathophysiological processes.
View Article and Find Full Text PDFHead Neck
September 2025
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Background: Flap complications following maxillectomy, reconstruction, and adjuvant proton beam therapy (PBT) for primary maxillary and sinonasal malignancies are not well described.
Methods: This retrospective cohort study included consecutive patients treated between 2016 and 2023 from a single-institutional database.
Results: Thirteen patients were identified with a median follow-up of 26 months.